Showing results (131-140 of 162) with videos related to
Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2025
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS G12V mutationsFelix John, Lea Ruge, Malte Verheyen, et al.Human Mutation|December 8, 2017
An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practiceGillian Ellison, Miika Ahdesmäki, Sally Luke, et al.Oncotarget|December 5, 2014
PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignanciesMatthias Scheffler, Marc Bos, Masyar Gardizi, et al.NPJ Precision Oncology|June 17, 2021
Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapyMartin Thelen, Kerstin Wennhold, Jonas Lehmann, et al.European Journal of Cancer (Oxford, England : 1990)|December 15, 2022
Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitorsRichard Riedel, Jana Fassunke, Hannah L Tumbrink, et al.Journal of Clinical Pathology|August 2, 2020
Predictive molecular pathology in the time of coronavirus disease (COVID-19) in EuropeUmberto Malapelle, Pasquale Pisapia, Antonino Iaccarino, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 12, 2012
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancerHans-Ulrich Schildhaus, Lukas C Heukamp, Sabine Merkelbach-Bruse, et al.Nature Communications|November 3, 2025
AI-powered spatial cell phenomics enhances risk stratification in non-small cell lung cancerSimon Schallenberg, Gabriel Dernbach, Sharon Ruane, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2026
ADC target profiling in NSCLC: Generalizable AI separates TROP-2 and cMET phenotypesPhilipp Anders, Marvin Sextro, Katja Lingelbach, et al.NPJ Precision Oncology|December 18, 2021
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancerDiana Schaufler, David F Ast, Hannah L Tumbrink, et al.Pageof 17